ArticleLeukemiaPublished
Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress response
24 of 38 authors shown in byline order.
Regional connection
Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, Philadelphia VA Medical Center, University of Pennsylvania, The Wistar Institute. Affiliation source
Publication record
- Type
- Article
- Venue
- Leukemia
- Published
- Topic
- Disease research
- Subject terms
- Cell Line, Tumor; Mitochondria; Animals; Humans; Mice; Reactive Oxygen Species; Mevalonic Acid; Polyisoprenyl Phosphates; Cytarabine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Drug Resistance, Neoplasm; Mutation
- PubMed ID
- 40634510
- PubMed Central ID
- PMC12380605
- Open access
- Yes, open
- Added to directory
- Source checked